LiGHT and Eagle: landmark glaucoma treatment studies
SLT versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Dr Shenton Chew6 min read
Advertisement
SLT versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
The theme of the second Ocular Therapeutics Evening (OTE) was anterior segment. Dr Sue Ormonde, the first of four guest speakers, opened by discussing the management of different forms of infective keratitis, emphasising that we should not use topical steroids until we know what we are treating. She
In theory, fitting scleral lenses for my dry eye patients was a logical evolution for both my dry eye and rigid gas permeable (RGP) contact lens practice specialities, but there were a few obstacles to making it a success in practice. Time was a significant issue. Dry eye patients typically have num
Almost as soon as pandemic and lockdown arrived, we were talking about the lasting changes this might bring: the ‘new normal’. I got a bit tired of hearing the phrase, but I was all on board for change. The world we know could be made better in so very many ways.
What? Me? Causing dry eyes? But how? In addition to treating dry eye disease (DED), many medical professionals, including eyecare providers, may be causing dry eyes. The primary ways we are increasing
In the early days of my clinical career, most products for managing dry eye disease (DED) focused on increasing eye lubrication using a limited range of ingredients. Although artificial tears remain a mainstay of DED management today, there now exists a plethora of products for eyecare practitioners
Scotland, like many places, has experienced a cycle of peaks and troughs in Covid-19 case numbers and corresponding restriction levels. I work as part of a wonderful team at Glasgow Caledonian University which has successfully adapted to these changing circumstances. We have an on-site Vision Centre
As research in dry eye disease continues to take important steps forward, industry partners have stepped up to bring an exciting range of multifunctional devices to market to assist practitioners in efficiently and effectively diagnosing and managing dry eye disease.
He aha te mea nui o te ao? He tangata he tangata he tangata. What is the most important thing in this world? It is people, it is people, it is people.
The first and second editions of this textbook were written by Professor David Pickwell, who specialised in binocular vision and ocular anatomy and physiology and was one of the first professors of
It is well recognised that tear film lipid layer instability is one of the hallmarks of evaporative dry eye disease (DED), yet most artificial tears are water-based and thus do little to replenish the disrupted lipid layer.
The job of the optics industry is to support those with visual impairment and prevent others from developing it, but for patients who are neurodiverse, such as those with autism spectrum disorder, more has to be done to meet their needs